Mark J Eisenberg
Overview
Explore the profile of Mark J Eisenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
275
Citations
7049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moiz A, Filion K, Tsoukas M, Yu O, Peters T, Eisenberg M
Am J Med
. 2025 Feb;
PMID: 39892489
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have become central in managing obesity and type 2 diabetes, primarily through appetite suppression and metabolic regulation. This review explores the mechanisms underlying GLP-1...
2.
Wennberg E, Abualsaud A, Eisenberg M
JACC Adv
. 2025 Jan;
4(1):101453.
PMID: 39801818
Percutaneous coronary intervention (PCI) is a mainstay procedure for the treatment of coronary artery disease. PCI techniques have evolved considerably since the advent of PCI in 1978, and with this...
3.
Moiz A, Filion K, Toutounchi H, Tsoukas M, Yu O, Peters T, et al.
Ann Intern Med
. 2025 Jan;
178(2):199-217.
PMID: 39761578
Background: Recent randomized controlled trials (RCTs) have investigated glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual or triple co-agonists for weight loss among adults with overweight or obesity and without...
4.
Peri K, Eisenberg M
Eval Health Prof
. 2025 Jan;
:1632787241311360.
PMID: 39749561
The goal of maintenance of certification (MOC) activities is to ensure physicians are up to date on current practices and demonstrate the knowledge and skills required to provide patients with...
5.
Almizel A, Levett J, Zolotarova T, Eisenberg M
Am J Cardiol
. 2024 Dec;
239:75-81.
PMID: 39674441
Patients with ST-segment elevation myocardial infarction (STEMI) frequently present with multivessel coronary artery disease (CAD) during primary percutaneous coronary intervention, and the optimal timing of complete revascularization (CR) in these...
6.
Kudrina I, Page M, Choiniere M, Shir Y, Eisenberg M, Ben-Sasson M, et al.
BMJ Open
. 2024 Oct;
14(10):e083791.
PMID: 39414287
Introduction: Millions of persons with chronic pain across North America and Europe use opioids. While the immunosuppressive properties of opioids are associated with risks of infections, these outcomes could be...
7.
Lyzwinski L, Dong M, Wolfinger R, Filion K, Eisenberg M
JMIR Public Health Surveill
. 2024 Sep;
10:e58260.
PMID: 39283667
Background: While smoking cessation has been linked to substantial weight gain, the potential influence of e-cigarettes on weight changes among individuals who use these devices to quit smoking is not...
8.
Dobromir Angheluta A, Levett J, Zolotarova T, Filion K, Seirafi T, Reynier P, et al.
JACC Adv
. 2024 Sep;
3(10):101204.
PMID: 39252859
Background: Drug-coated balloons (DCBs) may be a viable alternative to drug-eluting stents (DES) for de novo small caliber coronary artery lesions. However, there remains a lack of data regarding the...
9.
Jarade C, Zolotarova T, Moiz A, Eisenberg M
EClinicalMedicine
. 2024 Sep;
75:102789.
PMID: 39246720
Despite the availability of a wide range of antihypertensive agents, a significant proportion of individuals with resistant hypertension (RHTN) struggle to achieve blood pressure (BP) control. Obesity ranks among the...
10.
The use of venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a narrative review
Gedeon T, Zolotarova T, Eisenberg M
Eur Heart J Open
. 2024 Jul;
4(4):oeae051.
PMID: 38974874
Aims: Cardiogenic shock (CS) develops in up to 10% of patients with acute myocardial infarction (AMI) and carries a 50% risk of mortality. Despite the paucity of evidence regarding its...